Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 41.8154 | 12 |
GSM780708 | Untreated after 4 days (C2_1) | 38.0272 | 3 |
GSM780709 | Untreated after 4 days (C3_1) | 40.4935 | 8 |
GSM780719 | Untreated after 4 days (C1_2) | 42.5581 | 15 |
GSM780720 | Untreated after 4 days (C2_2) | 43.9927 | 22 |
GSM780721 | Untreated after 4 days (C3_2) | 45.2873 | 29 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 42.7947 | 17 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 42.8028 | 17 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 48.5714 | 43 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 42.693 | 16 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 40.5621 | 8 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 42.493 | 15 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 44.339 | 24 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 39.7351 | 6 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 43.353 | 19 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 43.8897 | 22 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 39.3153 | 5 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 40.5881 | 8 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 37.4174 | 2 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.8356 | 21 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 44.2084 | 23 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.2279 | 23 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 40.2896 | 7 |